Ugurel, S., Hassel, J. C., Schadendorf, D., & Utikal, J. (2014). A multicenter DeCOG study on predictors of vemurafenib therapy outcome in melanoma: Pretreatment impacts survival. Annals of oncology, 26(3), . https://doi.org/10.1093/annonc/mdu573
Chicago-Zitierstil (17. Ausg.)Ugurel, Selma, Jessica C. Hassel, Dirk Schadendorf, und Jochen Utikal. "A Multicenter DeCOG Study on Predictors of Vemurafenib Therapy Outcome in Melanoma: Pretreatment Impacts Survival." Annals of Oncology 26, no. 3 (2014). https://doi.org/10.1093/annonc/mdu573.
MLA-Zitierstil (9. Ausg.)Ugurel, Selma, et al. "A Multicenter DeCOG Study on Predictors of Vemurafenib Therapy Outcome in Melanoma: Pretreatment Impacts Survival." Annals of Oncology, vol. 26, no. 3, 2014, https://doi.org/10.1093/annonc/mdu573.